Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04298034
PHASE3

Preeclampsia Postpartum Antihypertensive Treatment

Sponsor: Medical College of Wisconsin

View on ClinicalTrials.gov

Summary

The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to either initiate antihypertensive treatment or standard of care. We hypothesize that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk of hospital readmission, healthcare utilization and the number of severe range blood pressures at postpartum follow-up visits.

Official title: Randomized Controlled Trial for Postpartum Antihypertensive Treatment of Women With Preeclampsia

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2020-07-17

Completion Date

2025-12-30

Last Updated

2025-10-23

Healthy Volunteers

No

Interventions

DRUG

Labetalol, Nifedipine

Antihypertensive treatment that is safe and well studied in peripartum women.

Locations (1)

Medical College of Wisconsin-Froedtert Hospital

Milwaukee, Wisconsin, United States